The global nucleic acid isolation and purification kits market, valued at US$2.82 billion in 2024, stood at US$3.02 billion in 2025 and is projected to advance at a resilient CAGR of 9.8% from 2025 to 2030, culminating in a forecasted valuation of US$4.82 billion by the end of the period. The growth of the nucleic acid isolation and purification kits market is mainly driven by the growth in molecular diagnostics and sequencing-based testing. Labs are running more PCR/RT-PCR panels, syndromic testing, and oncology and genetic assays. This directly aids in the growth of consumption of extraction kits across routine workflows.
The nucleic acid isolation and purification kits market is expanding steadily as more laboratories require reliable and repeatable extraction for routine and high-volume workflows. Demand is increasing from hospital labs, reference labs, public health labs, and research centers that routinely run large numbers of molecular tests. There is also an observed shift toward standardized, automation-ready extraction. This is aiding innovation and growth in the market. Additionally, with a widening sample mix, the adoption and demand for specialty kits are growing.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36573704
KEY TAKEAWAYS
- North America accounted for a 43.0% revenue share of the nucleic acid isolation and purification kits market in 2024.
- By type, the DNA extraction kits segment accounted for the largest share of the nucleic acid isolation and purification kits market in 2024.
- By method, the magnetic bead-based method segment dominated the market in 2024.
- By application, the personalized medicine segment is projected to grow at the fastest rate of 10.5% from 2025 to 2030.
- By end user, the pharmaceutical & biotechnology companies segment is projected to grow at the fastest rate of 11.0% from 2025 to 2030.
- Companies such as Thermo Fisher Scientific, QIAGEN, and F. Hoffmann-La Roche were identified as key players in the nucleic acid isolation and purification kits market, given their strong market share and extensive product footprint.
- Companies such as HiMedia Laboratories and Caisson Labs, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
Driver: Clinical NGS expansion in oncology and precision testing
Tumor profiling is shifting to routine use in many centers. Guidelines increasingly recommend NGS in several advanced cancers. As NGS testing expands, upstream sample prep is becoming a core requirement. Labs need consistent yield and purity to avoid sequencing failure. This supports steady demand for extraction and clean-up kits. It is also increasing the use of higher-performance kits for low-input and mixed samples.
Opportunity: Automation-first magnetic bead kits and high-throughput formats
Laboratories are increasingly transitioning to plate-based and automated extraction systems. Bead-based kits are highly compatible with robotics and standardized protocols, paving the way for fully automated workflows and ready-to-use reagents. Vendors can gain a competitive advantage by enhancing speed, yield, and contamination control. Additionally, there is a growing demand for instrument-agnostic kits that are compatible with various platforms. Consequently, forming automation partnerships and validating workflows can help expand market share.
Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=36573704
Nucleic Acid Isolation and Purification Kits Market, by Type
In 2024, the DNA extraction kits segment dominated the nucleic acid isolation and purification kits market. This is mainly because a wide range of high-volume workflows rely on DNA preparation as the first step. Routine clinical molecular testing, genetic screening, and oncology assays often begin with the extraction of genomic DNA from blood, saliva, and tissue. DNA is also more stable than RNA, making handling and storage easier in routine laboratory operations.
Nucleic Acid Isolation and Purification Kits Market, by Application
In 2024, diagnostics is the dominant application in the nucleic acid isolation and purification kits market. This is mainly because clinical labs run extraction as a routine step before PCR/RT-PCR and other molecular assays. Infectious disease testing remains a high-volume driver, supported by respiratory panels, STI testing, and hospital-acquired infection screening.
Asia Pacific to be the fastest-growing region in the nucleic acid isolation and purification kits market during the forecast period
The nucleic acid isolation and purification kits market in the Asia Pacific region is experiencing significant expansion. The increasing use of molecular diagnostics and the growing number of PCR and syndromic testing in countries such as China, Japan, India, South Korea, and Singapore are major contributors to the market growth in this region. The local spending on genomics, public health surveillance, and hospital lab capacity is leading to an increase in routine extraction volumes.
Key companies active in the nucleic acid isolation and purification kits market include Thermo Fisher Scientific (US), QIAGEN (Germany), F. Hoffman-La Roche (Switzerland), Agilent Technologies, Inc. (US), and Takara Bio Inc. (Japan), along with other regional and global companies.
Inquire Now: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=36573704